search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CONTENTS


Contents


7. 8.


Chapter 1: Outsourcing supply operations


Hybrid 2.0: the role of real-time data technology in IMP distribution and cell and gene therapy as a next step of innovation Addressing sustainability concerns in logistics


10.


Quality and sustainability: the balancing act for pharma manufacturing Unpicking the CPHI Europe meeting


13.


The tipping point of outsourcing: to build internally or seek external help? Debating the pros and cons of outsourcing


16. 17.


Chapter 2: Technology and innovation


How your RTSM can give you what you need to save on supply cost The drive to reduce costs by anticipating uncertainties


19.


DCTs no longer? Decentralised solutions in post-pandemic clinical trials Analysing the role of decentralised trial elements in the wake of Covid-19


22.


Successfully implementing interactive response technology: from selection to execution Essential advice on finding the right provider of IRT software solutions


31. 32.


25. 26.


Chapter 3: Supply and logistics


The ‘top-down view’ Why supply and logisitics are a vital piece of the clinical trials puzzle


29.


Is there a general checklist available to assist with importing biological materials into the United States? Important guidance for businesses and researchers


Chapter 4: Future supply models


Advancing quality control measures vital for cell and gene therapy development Why it’s important to ditch pen and paper methods


34.


Relabelling the clinical trial landscape Digital Display Labels: what are they and how do they work?


37.


The future of clinical supply chain models: leading the transformation How collaboration can help increasingly complex clinical trials


40. Suppliers’ directory


6 | Clinical Trial Supply Handbook


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44